News Corp eyes joint Telegraph bid with rivals, Bloomberg News reports-February 2024-www.financetom.com

News Corp eyes joint Telegraph bid with rivals, Bloomberg News reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

News Corp eyes joint Telegraph bid with rivals, Bloomberg News reports

Mar 11, 2024 1:41 PM

March 11 (Reuters) - Rupert Murdoch's News Corp ( NWSA )

and the owner of the Daily Mail have held talks about a

potential joint takeover of the Telegraph alongside the

UAE-backed investment fund RedBird IMI, Bloomberg News reported

on Monday, citing people familiar with the matter.

(Reporting by Ananya Mariam Rajesh in Bengaluru)

Previous page： Cypherpunk Technologies' Q3 net loss narrows Next page： Apparel retailer LightInTheBox Q3 net income jumps, revenue drops on margin focus

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Cypherpunk Technologies' Q3 net loss narrows

Nov 12, 2025

Overview * Cypherpunk Technologies reports Q3 net loss of $3.3 mln, down from $18.2 mln last year * Company acquires 203,775 ZEC for $50 mln as part of digital asset strategy * Closed $58.88 mln private placement led by Winklevoss Capital for digital asset strategy Outlook * Company did not provide specific financial guidance for future quarters or year Result...

Apparel retailer LightInTheBox Q3 net income jumps, revenue drops on margin focus

Nov 12, 2025

Overview * LightInTheBox ( LITB ) Q3 net income rises to $2.8 mln from $0.3 mln last year * Company Q3 revenue declines 3% yr/yr, reflecting focus on margin preservation * Gross margin improves to 66.9% from 61.1% last year, driven by high-margin products Outlook * LightInTheBox ( LITB ) expects overall revenue growth in 2026 * Company plans broader...

Corbus Pharma Q3 net loss widens to $23.3 mln

Nov 12, 2025

Overview * Corbus Pharmaceuticals ( CRBP ) Q3 net loss widens to $23.3 mln, driven by clinical development costs * Company completed $75 mln public offering, extending cash runway into 2028 * CRB-701 clinical data shows promising ORR in HNSCC, cervical, and bladder cancers Outlook * Company plans to meet FDA in Q1 2026 for CRB-701 data review * Corbus...

Coya Therapeutics' Q3 net loss narrows

Nov 12, 2025

Overview * Coya Therapeutics ( COYA ) Q3 net loss narrows to $2.1 mln from $4.0 mln last year * Company reports $3.6 mln collaboration revenue due to IND approval milestone * Coya completes $23 mln public offering, extending cash runway into 2H 2027 Outlook * Company expects to receive $4.2 mln milestone payment upon first patient dosing in ALS...